New Expensive Anticancer Agents: Which Role Is Played by Quality-Adjusted Life-Years in the Selection of a Specific Treatment?

TO THE EDITOR: Koczwara et al emphasize that dissemination and implementation science should broaden its reach beyond its current geographic limits (including the United States, the United Kingdom, Canada, and Australia). However, even within these limits, critical issues remain in the field of oncology. In fact, although evidence behind cancer control strategies may not differ around the globe, other critical points, such as how pharmacoeconomic concepts are applied in various health care systems, show important geographic variations that deserve close scrutiny.